Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial

These results indicate marked heterogeneity of expression of metabolism-associated markers in ovarian cancer; however, there was a lack of association with clinical benefit after chemotherapy/anti-vascular endothelial growth factor treatment. Notwithstanding the lack of prognostic value, knowledge of the pattern of expression of these biomarkers in tumors can be useful for patient stratification purposes when new drugs targeting these metabolic pathways will be tested.

Authors

Institutions

Publication Details

Journal
The International Journal of Biological Markers
Published
2024-11-01
DOI
https://doi.org/10.1177/03936155241296164
Citations
1
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial

Alessandra Bologna, Simona Signoriello, Saverio Cinieri, Grazia Artioli et al.
1 citations
The International Journal of Biological Markers
Cancer, Hypoxia, and Metabolism
0.29
article

Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial

Alessandra Bologna, Simona Signoriello, Saverio Cinieri, Grazia Artioli, Federica Perrone, Ilaria Piga, Annamaria Ferrero, Laura Arenare, Stefano Indraccolo, Carmela Pisano, Fabrizio Ferrarini, Daniela Califano, Germana Tognon, Carolina Bottoni, Vittorio Simeon, Paolo Chiodini, Giosuè Scognamiglio, Eliana Bignotti, Anna Spina, Andrea Boscolo Bragadin, Giovanni Esposito, Daniela Russo, Sandro Pignata, Vanda Salutari
article en
1 citations

Abstract

These results indicate marked heterogeneity of expression of metabolism-associated markers in ovarian cancer; however, there was a lack of association with clinical benefit after chemotherapy/anti-vascular endothelial growth factor treatment. Notwithstanding the lack of prognostic value, knowledge of the pattern of expression of these biomarkers in tumors can be useful for patient stratification purposes when new drugs targeting these metabolic pathways will be tested.

The International Journal of Biological MarkersVol. 39(4)
Università Cattolica del Sacro Cuore (IT), University of Padua (IT), University of Campania "Luigi Vanvitelli" (IT), Agostino Gemelli University Polyclinic (IT), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), AULSS 2 Marca Trevigiana (IT), Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (IT), Ospedale A. Perrino (IT), Istituto Oncologico Veneto (IT), University of Campania "Luigi Vanvitelli" (IT), A. O. Ordine Mauriziano di Torino (IT), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Ministero della Salute, Associazione Italiana per la Ricerca sul Cancro
Good health and well-being, Zero hunger
Openalex Percentile: Top 38%
Cancer, Hypoxia, and Metabolism
0.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.